> Advertise medical cures that the government doesn't approve of
There is nothing wrong with advertising the truth that certain medical treatments exist which are not government approved in the US, or, legal in the US, but are defintely viable, and are actively used in other parts of the world, or, could be by physicians for off-label use.
domperidone [1] is a drug that is used for a few indications overseas. There is an active discussion around it on a number of social media sites, but the FDA warns against importing it, for violating an FDA Act. It is possible to get an exception for one indication in the US, potentially...... But, many women want it because it helps with lactation, and for a woman with a hungry infant, this is a big issue. You get a screaming baby that wants 8 oz more of milk a day, and lemme tell you, can't negotiate with a screaming baby! Off Label uses of medications also, is common among Physicians. Viagra is one drug that has a number of utilities in off-label use.
BigTech squelching the conversation around Domperidone is fairly similar to BigTech squelching the standard COVID treatment protocols [2], from Zelenko [3] & McCullough [4], which will likely become standard of care fairly shortly, and are now in evidence on CDC websites too [5], but significantly trailing the most updated protocols. But they don't squelch Domperidone talk, and the reason is simple. Pushing vaxxes are a big priority for the govt, while going after the discussion of secrets for increasing breastmilk outputs would probably be bad optics.
> actual violations of the law, at least in the United States.
Covid protocols have nothing to do with actual violations of Law, and, they will be standard of care shortly, as the CDC website writing [5] is on the wall.
[1] https://pubmed.ncbi.nlm.nih.gov/30000430/
[2] https://www.wired.com/story/stop-ignoring-the-evidence-on-co...
[3] https://vladimirzelenkomd.com/zelenko-prophylaxis-protocol/
[4] https://www.youtube.com/watch?v=QAHi3lX3oGM
[5] https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guida...